“Upon the product’s registration, CanSino will be partnering with Solution Biologics in the supplying of bulk product for further manufacturing (fill and finish) of the finished product, its final quality control release and its commercialisation by Solution Biologics in Malaysia,” Solution Group said.
it was up steadily for the past week (traders bought on rumours of the approval may be granted) and when the news were out yesterday, hence the sell down (conditional approval for now).
How much they can make from 3.5 million doses ?? Share prices had shot up 7 times (700%). Obviously the right path now is downwards when order confirmed
Chinese troops get COVID-19 vaccine By Leng Shumei Source: Global Times Published: 2020/11/20 19:38:40
No one infected despite exposure in epidemic-hit areas
Many Chinese military personnel, including peacekeeping personnel, have received a COVID-19 vaccine developed by Tianjin-based CanSino Biologics, and none of them got infected after vaccination, Yu Xuefeng, CanSino chairman and CEO, told a forum on Friday.
CanSino announced in June that Ad5-nCoV, a recombinant novel coronavirus vaccine the company developed with a military research team led by the military medical expert Chen Wei, had received a special one-year military drug approval.
At the Qiming Venture Partners CEO Summit, Yu said that the vaccine had been used on many military personnel, including peacekeeping team members working in epidemic affected areas.
None of them were infected after vaccination, and we are confident in our vaccine, Yu noted.
The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that its wholly-owned subsidiary Solution Biologics Sdn Bhd (“SOLBIO”), had on 16 June 2021 received the product registration conditional approval from Drug Control Authority for its CONVIDECIA (Trade Mark) Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for emergancy use. The vaccine is for the prevention of COVID-19.
The vaccine was jointly developed by CanSino Biologics Inc. and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, which only require single dose.
How come Yong Tai's vaccine and factory in 'talking stage' can go up while Solutn's vaccine already approved by NPRA for use in Malaysia and their production facility already ready and yet share price can't go up geh ?
On up trend now....note the big advantage: CONVIDECIA is SINGLE DOSE vaccine, should be in high demand due to this convenience especially for busy ppl and ppl in remote areas!
Still got hope to reach back 2?? Lets c what is in hand for next week AGM n what kind of prospect can they gain from cansino when the vaccine is rolling out starting next month.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
U1818
707 posts
Posted by U1818 > 2021-06-15 15:29 | Report Abuse
https://themalaysianreserve.com/2020/09/24/solution-group-unit-inks-deal-with-cansino-for-vaccine-distribution/
“Upon the product’s registration, CanSino will be partnering with Solution Biologics in the supplying of bulk product for further manufacturing (fill and finish) of the finished product, its final quality control release and its commercialisation by Solution Biologics in Malaysia,” Solution Group said.